Innovative Reflux Portfolio Showcased at Thailand Medical Fair, with Rapid Pepsin Test Drawing Key Interest

A comprehensive suite of reflux management solutions attracted significant attention from a global medical audience at a major healthcare exhibition in Thailand. The products were presented by a joint team of R&D engineers from RD Biomed Ltd (UK) and Maxhealth Innovative Meditech, engaging with healthcare professionals and distributors from regions including Thailand, the Philippines, India, Hong Kong, and the United States.

Among the showcased portfolio—which included the established Peptest laboratory test and the alginate-based Gasrelief physical barrier therapy, the Pepfast rapid on-site test garnered the highest volume of inquiries.

“The intense interest in Pepfast was evident,” noted an attending R&D engineer. “Its design for quick, objective results aligns with the practical need for efficient clinical screening and patient engagement that we heard from many visitors.”

A Portfolio for the Clinical Pathway

The engagement highlighted the value of having solutions for different stages of reflux management:

• Pepfast was recognized for enabling rapid, on-site screening.
• Peptest was discussed for its role in confirmatory diagnosis and treatment monitoring.
• Gasrelief was noted as a non-systemic option for immediate symptom relief.

Facilitating Global Dialogue

The exhibition served as a productive platform for direct technical and clinical dialogue with potential partners, supporting the future introduction of these solutions to more healthcare markets.